Free shipping from 69,00 €
Get free shipping with a minimum spend of 69,00 €. Or by purchasing one of the selected products. Discover them now!
Citrosil 0.175% - disinfectant cutaneous solution 200 ml
-
200 ml€2.81
-
100 ml€3.33
-
8 bottlesNot available
Information on returns and shipments
Payment methods
Medicines authorized by the Ministry of Health
Skin Solution, Disinfectant
Disinfection and cleaning of skin, including damaged skin (wounds, grazes, abrasions, burns).
Contraindications/Side effects
Hypersensitivity to the active ingredient or to any of the excipients listed, do not administer to children under 1 year of age.
Dosage
Method of administration: solution. Ready-to-use solution. Must be used neat. Intact skin: rub the affected area with gauze soaked in solution. Superficial lesions: apply the product with a sterile gauze compress. Apply two to three times a day. Spray: Spray on the area to be treated two or three times a day. Do not exceed the recommended dose.
Warnings
The product is for external use only. Avoid contact with eyes, brain, meninges, and middle ear. Do not use for prolonged treatments. Do not use for the disinfection of mucous membranes. The use, especially if prolonged, of topical products may give rise to sensitization phenomena; in this case, discontinue treatment. Accidental ingestion or inhalation of some disinfectants can have serious, sometimes fatal, consequences. Avoid exposure to ultraviolet rays (sun or artificial sources) after applying the product.
Interactions
Avoid the simultaneous use of other antiseptics and detergents. Paediatric population: Interaction studies have only been performed in adults.
Undesirable effects
The following adverse reactions have been identified after the authorization of the use of benzalkonium chloride. Since these reactions derive from spontaneous reports, it is not always possible to define their frequency. In some cases, intolerance (burning or irritation) may occur, although this is inconsequential and does not require modification of treatment. Paediatric population: The same frequency, type, and severity of adverse reactions are expected in the paediatric population as in the adult population. Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product.
Pregnancy and breastfeeding
The product should be used only in cases of real need. During breastfeeding, avoid applying the product to the breast to prevent ingestion of the product by the infant.
Format
Price Trend
This product has been on sale since 25/09/2017
In the last 30 days, the product's lowest price was 2,81 €